On PND5, genistein exposure did not alter basal mRNA expression of Gilz, Fkbp5, Klf13, or Per1, 11[beta]hsdII, or the reference gene peptidylprolyl isomerase
B (Ppib) (Figure 1B), although basal expression of Sgk1 was significantly higher and basal expression of Il13ra2 was significantly lower in the genistein-exposed mice.
Bars represent DENV RNA copy number (relative to cellular peptidylprolyl isomerase
A (PPIA)) or mean pfu/mL, with error bars showing standard deviation.
Nomenclature P[O.sub.2]: Oxygen partial pressure ATP: Adenosine triphosphate Rplp1: Ribosomal protein P1 Ppia: Peptidylprolyl isomerase
A Rnr1: RNA ribosomal 1 Hif-1[alpha]: Hypoxia-inducible factor 1 alpha Ptgs2/Cox-2: Prostaglandin-endoperoxide synthase 2 Hmox1/Ho-1: Heme oxygenase 1 ROS: Reactive oxygen species IEQ: Islet Equivalents.
FKBP38 peptidylprolyl isomerase
promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum.
Ppia (peptidylprolyl isomerase
A (cyclophilin A)) was used as an internal control for SYBR Green PCR, which was performed in a single tube in triplicate.
In this context, a recent comprehensive study of the OVCAD (OVarian CAncer Diagnosis) consortium, analyzing a cohort of 216 patients, found that peptidylprolyl isomerase
C (cyclophilin C) (PPIC)positive CTC were significantly more abundant in platinum-resistant than in platinum-sensitive patients (32).
Control samples included the expressed pig genes encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein L24 (RPL24), eukaryotic translation elongation factor 1 alpha 1 (EEF1A1), glutathione peroxidase 1 (GPX1), and peptidylprolyl isomerase
A (cyclophilin A) (PPIA).
 Human genes: PPIA, peptidylprolyl isomerase
A (cyclophilin A); PPP3R1, protein phosphatase 3, regulatory subunit B, a; PPP3CA, protein phosphatase 3, catalytic subunit, a isozyme; PPP3CB, protein phosphatase 3, catalytic subunit, isozyme; FKBP1A, FK506 binding protein 1A, 12 kDa; CALM1, calmodulin 1 (phosphorylase kinase, 8); IL2, interleukin-2; IL2RA, interleukin 2 receptor, a; JUN, jun proto-oncogene; NFATC1, nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1.
 Human genes: CDH16, cadherin 16, KSP-cadherin; HIF1A, hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor); HPRT1, hypoxanthine phosphoribosyltransferase 1; PPIA, peptidylprolyl isomerase
A (cyclophilin A); KLK3, kallikrein-related peptidase 3; TBP, TATA box binding protein; RN18S1, RNA, 18S ribosomal 1; MIR155HG, MIR155 host gene (nonprotein coding).
 Human genes: RPLPO, ribosomal protein, large, P0; PPIA, peptidylprolyl isomerase
A (cyclophilin A); TNFRSF1A, tumor necrosis factor receptor superfamily, member 1A; CCL11, CCL17, CCL19, CCL22, CCL3, CCL4, chemokine (C-C motif) ligand 11, 17, 19, 22, 3, and 4; CL5 chemokine (C-C motif) ligand 5; CCR1, CCR7, CCR8, chemokine (C-C motif) receptor 1, 7, and 8; CD86, CD86 molecule; CXCL12, chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXCL2, chemokine (C-X-C motif) ligand 2; CXCR4, chemokine (C-X-C motif) receptor 4; L128, interleukin 12B (natural killer cell-stimulating factor 2, cytotoxic lymphocyte maturation factor 2, p40); IL15, IL4, IL8, interleukin 15, 4, and 8; HPRT1, hypoxanthine phosphoribosyltransferase 1; PGK1, phosphoglycerate kinase 1.
 Human genes: LPL, lipoprotein lipase; ZAP70, zeta-chain (ICR) associated protein kinase 70 kDa; PPIA, peptidylprolyl isomerase
A (cyclophilin A); LMNB1, lamin B1; EIF1AX, eukaryotic translation initiation factor 1A, X-linked; CASC3, cancer susceptibility candidate 3; IGHV, immunoglobulin variable heavy chain region; PGKI, phosphoglycerate kinase 1; CD38, CD38 molecule.
Human genes: FASLG, Fas ligand (INF superfamily, member 6); PPIA, peptidylprolyl isomerase
A (cyclophBin A); BCL2, B-cell CLL/lymphoma 2